Bowen Sharn L, Bloor Balvinder K, Leigh Irene M, Waseem Ahmad
Head and Neck Cancer Research Programme, GKT Dental Institute, King's College London, London, UK.
J Pathol. 2003 Sep;201(1):119-26. doi: 10.1002/path.1389.
Adducin is a heterodimer of alpha- with beta- or gamma-subunits that regulates the assembly of the spectrin-based membrane skeleton in erythrocytes. Although adducin has been identified in various non-erythroid cells and tissues, it has been localized at intercellular junctions only in keratinocytes and epidermis. However, no data are available yet on the regulation of individual adducin genes in differentiating versus hyperproliferating keratinocytes. Due to the unavailability of mono-specific antibodies for individual adducins, this study has used RT-PCR and in situ hybridization to investigate the expression of alpha- and beta-adducins in cultured cells and in stratified epithelia including cutaneous and oral lesions. Using RT-PCR, the alpha-transcripts were consistently expressed in all cell lines tested, as well as in normal interfollicular epidermis, whereas the beta-transcripts were more variable and were strongly expressed in K562, A431, and primary keratinocytes. However, in normal skin, oral mucosa, and attached gingivae, the levels of alpha-transcripts closely paralleled those for the beta-subunit. In most normal tissues, adducin expression was observed primarily in the proliferating compartments including the basal layer and lower suprabasal layers. Expression of both genes was also up-regulated in skin diseases characterized by increased cell proliferation and keratinocyte activation, such as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and psoriasis. It was observed that, in most cases, the expression of both alpha- and beta-adducin was accompanied by increased expression of the proliferation marker Ki-67 and keratins K6 and K16. Differentiating keratinocytes in normal epithelia as well as in tumours appear to suppress the expression of adducin transcripts. The data suggest that the expression of adducin genes may be linked to cell proliferation and starts to down-regulate at the onset of differentiation.
内收蛋白是一种由α亚基与β或γ亚基组成的异二聚体,可调节红细胞中基于血影蛋白的膜骨架的组装。尽管在内收蛋白已在各种非红细胞细胞和组织中被鉴定出来,但它仅在角质形成细胞和表皮的细胞间连接处定位。然而,关于在分化的角质形成细胞与过度增殖的角质形成细胞中单个内收蛋白基因的调控,目前尚无相关数据。由于缺乏针对单个内收蛋白的单特异性抗体,本研究使用逆转录聚合酶链反应(RT-PCR)和原位杂交技术,来研究α和β内收蛋白在培养细胞以及包括皮肤和口腔病变在内的复层上皮中的表达。使用RT-PCR技术,α转录本在所有测试的细胞系以及正常毛囊间表皮中均持续表达,而β转录本的表达则更具变异性,在K562、A431和原代角质形成细胞中强烈表达。然而,在正常皮肤、口腔黏膜和附着龈中,α转录本的水平与β亚基的水平密切平行。在大多数正常组织中,内收蛋白的表达主要在包括基底层和基底上层下部的增殖区室中观察到。在以细胞增殖增加和角质形成细胞活化特征的皮肤疾病中,如基底细胞癌(BCC)、鳞状细胞癌(SCC)和银屑病,这两种基因的表达也上调。据观察,在大多数情况下,α和β内收蛋白的表达都伴随着增殖标志物Ki-67以及角蛋白K6和K16表达的增加。正常上皮以及肿瘤中正在分化的角质形成细胞似乎会抑制内收蛋白转录本的表达。这些数据表明,内收蛋白基因的表达可能与细胞增殖相关,并在分化开始时开始下调。